Day: November 6, 2025

Correction: The consolidated cash flow statement on page 22 has been corrected, as well as the cash flow-related figures in the Key Financial Indicators table on page 11. All other information remains unchanged.GROUP CEO’S REVIEW The Estonian real estate market in the third quarter of 2025 was characterized by stable and moderately recovering activity. The number of transactions remained at a comparable level to the previous quarter, indicating that the market is adapting after the cooling of recent years. The average price per square meter of apartments showed a slight upward trend, particularly in the more active areas of Tallinn, where demand for high-quality residential space remains strong. The market continued to be influenced by high interest rates and buyer caution, which kept transaction activity under control. At the same time,...

STMicroelectronics empowers data-hungry industrial transformationwith unique dual-range motion sensorUnique MEMS innovation means deeper contextual awareness for monitoring and safety equipment also in harsh environments Richly detailed motion and event tracking with simultaneous, independent sensing in high-g and low-g ranges Integrates ST’s advanced in-sensor edge AI for autonomy, performance, and power savingGeneva, Switzerland – November 6, 2025 — STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, has revealed the ISM6HG256X, a tiny three-in-one motion sensor for data-hungry industrial IoT applications, serving as an additional catalyst for edge AI advancement. This smart, highly accurate IMU sensor uniquely combines simultaneous detection of low-g (±16g)...

REYKJAVIK, ICELAND and LONDON, UK (November 06, 2025) — Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorisations for all four presentations of Gobivaz®, Alvotech’s biosimilar to Simponi® (golimumab). The authorisations cover Gobivaz® 50 mg/0.5 mL and 100 mg/mL presentations in both pre-filled syringe and autoinjector formats, for the treatment of rheumatoid arthritis, psoriatic arthritis, axial spondylarthritis, ulcerative colitis in adults, and...

Focusing on early applications in policing, campus safety, and commercial security, Wrap and LETAC seek to establish the rules of engagement for drone-based systems that advance public safety through non-lethal response MIAMI, Nov. 06, 2025 (GLOBE NEWSWIRE) — Wrap Technologies, Inc. (NASDAQ: WRAP), a global leader in non-lethal response and public-safety technology solutions, today announced a landmark partnership with Law Enforcement Training Academies and Consulting (LETAC) USA by Eckberg Lammers, P.C., a premier public safety, school, and corporate policy and training authority, to co-develop the first known Non-Lethal Response: Machine-to-Man Policy Framework & Development initiative. We believe this partnership represents a historic step in shaping how autonomous and semi-autonomous systems interact safely, lawfully,...

In-Vitro Data Confirms Strong Protection Against H1N1 Influenza via Physical Barrier Mechanism Ra’anana, Israel, Nov. 06, 2025 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company developing intranasal products based on its proprietary Capture & Contain (C&C) platform, today announced positive in-vitro results for its product candidate, the PL-16 Viral Blocker, a proprietary nasal gel formulation, confirming a broad-spectrum viral blocking efficacy and reversible physical mechanism. Polyrizon’s formulation was evaluated for its ability to block infection by multiple respiratory viruses, including the influenza virus H1N1, using cell models. The results demonstrated a strong protective effect, as pre-treatment with the formulation effectively prevented viral-induced...

Fitell CorporationAI-Driven Advanced Robotic SystemsFitell CorporationAI-Driven Advanced Robotic SystemsTaren Point, Australia, Nov. 06, 2025 (GLOBE NEWSWIRE) — Fitell Corporation (NASDAQ: FTEL) (“Fitell” or the “Company”) today announced that it has entered into a securities purchase agreement with a U.S. based institutional investor to issue a $50 million convertible note. The financing will support the launch of 2F Robotics, a joint venture focused on developing and commercializing AI-driven robotic technologies across consumer and industrial applications. Key HighlightsStablecoin Financing:The net proceeds from the $50 million financing will be converted to stablecoin assets and held with a U.S. custodian. Stablecoin assets may be allocated toward 2F Robotics, the Company’s corporate treasury, or the Company’s...